kw.\*:("Anticoagulante")
Results 1 to 25 of 20768
Selection :
Interaction of warfarin with human serum albumin: a stoichiometric descriptionLARSEN, F. G; LARSEN, C. G; JAKOBSEN, P et al.Molecular pharmacology. 1985, Vol 27, Num 2, pp 263-270, issn 0026-895XArticle
Utilité de la surveillance biologique de l'héparinothérapie à visée curative = Usefulness of a biological supervision during curative heparinotherapyDEMICHELIS, C; COHEN, S; BRAGUER, D et al.Journal de pharmacie clinique (Paris). 1984, Vol 3, Num 3-4, pp 367-373, issn 0291-1981Article
Anticoagulantly active heparin-like molecules from mast cell-deficient miceMARCUM, J. A; MCKENNEY, J. B; GALLI, S. J et al.American journal of physiology. Heart and circulatory physiology. 1986, Vol 19, Num 5, pp H879-H888, issn 0363-6135Article
Heparin: applications and future prospectsQUICK, D; TROWBRIDGE, A. A.Chest. 1985, Vol 88, Num 5, pp 755-757, issn 0012-3692Article
The new understanding of the drug heparinJAQUES, L. B.Chest. 1985, Vol 88, Num 5, pp 751-754, issn 0012-3692Article
Hémostase Nouveaux anticoagulants: bien les connaître pour bien les prescrire : NOUVEAUTES EN MEDECINE 2011 (DEUXIEME PARTIE) = New anticoagulants: to know them in order to prescribe them appropriatelyBOEHLEN, F; DE MOERLOOSE, P.Revue médicale suisse. 2012, Vol 8, Num 324, pp 96-99, issn 1660-9379, 4 p.Article
Contra: Antidotes for novel anticoagulants? ― Do we really need themEERENBERG, Elise S; LEVI, Marcel; BULLER, Harry R et al.Thrombosis and haemostasis. 2012, Vol 108, Num 4, pp 623-624, issn 0340-6245, 2 p.Article
Frequency of attendance at anticoagulant clinics: a prospective studyHOWARD, M. R; MILLIGAN, D. W.British medical journal (1857). 1988, Vol 296, Num 6626, issn 0007-1447Article
The influence of maintaining the correct whole blood-to-anticoagulant ratio during donation on the quality of leukoreduced whole bloodKARGER, Ralf; LUKOW, Christian; KRETSCHMER, Volker et al.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 7, pp 1486-1492, issn 0041-1132, 7 p., 1Article
New anticoagulants ― how do they work ?KOZEK, S.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, issn 0001-5164, p. 125Conference Paper
Les héparines = HeparinsLa Revue du praticien (Paris). 1988, Vol 38, Num 15, pp 917-964, issn 0035-2640, 44 p.Article
Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brainISHII, H; SALEM, H. H; BELL, C. E et al.Blood. 1986, Vol 67, Num 2, pp 362-365, issn 0006-4971Article
Safe anticoagulation with danaparoid in pregnancy and lactationSCHINDEWOLF, Marc; MOSCH, Gerlinde; BAUERSACHS, Rupert M et al.Thrombosis and haemostasis. 2004, Vol 92, Num 1, issn 0340-6245, p. 211Article
Antithrombins : their potential as antithrombotic agentsWEITZ, J. I; HIRSH, J.Annual review of medicine. 1992, Vol 43, pp 9-16, issn 0066-4219Article
Un accident rare des anticoagulants: l'hémopéritoine par rupture vésiculaire: revue de la littérature à propos d'un cas = A rare complication of anticoagulant therapy: hemoperitoneum due to vesicular rupturePISSAS, A; DANEL, V; FINET, P et al.Journal de chirurgie (Paris. 1908). 1985, Vol 122, Num 4, pp 235-245, issn 0021-7697Article
Nouveaux anticoagulants : MALADIE THROMBOEMBOLIQUE VEINEUSE = New anticoagulants : VENOUS THROMBOEMBOLISMGODIER, Anne; MARTIN, Anne-Céline; LAKHDARI, Mourad et al.La Revue du praticien (Paris). 2011, Vol 61, Num 9, pp 1239-1243, issn 0035-2640, 5 p.Article
Etude et amélioration de l'usage des anticoagulants oraux dans un service hospitalier : évaluation des pratiques du service de cardiologie du centre hospitalier de SeclinROCHE, François-Xavier.2011, 72 p.Thesis
Heparin has its risks = L'héparine n'est pas sans risqueBROUHTON, Sandra.L'INFIRMIERE CANADIENNE. 1995, Vol 91, Num 8, pp 25-28, issn 1492-5494Article
Modern anticoagulant agents: Are they worth the investment?RACINE, Eric.American journal of health-system pharmacy. 2002, Vol 59, issn 1079-2082, 20 p., SUP6Serial Issue
Anticoagulant therapy with warfarinPAUL, B.Central african journal of medicine. 1990, Vol 36, Num 8, issn 0008-9176, p. 199Article
Computer control of anticoagulant dose for therapeutic managementRYAN, P. J; GILBERT, M; ROSE, P. E et al.British medical journal (1857). 1989, Vol 299, Num 6709, pp 1207-1209, issn 0007-1447, 3 p.Article
Scale-up of Myxalin purification by a pseudoaffinity method using a radial flow columnAKOUM, A; VIJAYALAKSHMI, M. A; SIGOT, M et al.Chromatographia (Wiesbaden). 1989, Vol 28, Num 3-4, pp 157-160, issn 0009-5893, 4 p.Article
Composition en glucides et activité anticoagulante du sang des polysaccharides soufrés contenant du fucose présents dans neuf espèces d'algues brunesNISHINO, T; NAGUMO, T.Nippon Nōgei Kagakukaishi. 1987, Vol 61, Num 3, pp 361-363, issn 0002-1407Article
Management of the anticoagulated patient for elective surgeryBORMAN, R. J; DANBY, D; TURNER, R. C et al.The Journal of foot surgery. 1991, Vol 30, Num 3, pp 308-309, issn 0449-2544, 2 p.Article
Heparin in angiography: current patterns of useMILLER, D. L.Radiology. 1989, Vol 172, Num 3, pp 1007-1011, issn 0033-8419, 5 p.Article